Lantus combined with Levemir

Reports:

Reaction Outcome Event Date Age Sex Weight Reported Reporter Country Treatment
Role Name
Weight Increased 10/5/2005 59 Female 168 lb 4/17/2006 Consumer United States
Primary
Secondary
Concomitant
Injection Site Nodule 4/1/2006 7/21/2006 Other Health Professional United States
Primary
Concomitant
Gastric Ulcer Hospitalization 80 Female 9/21/2006 Consumer United States
Primary
Secondary
Concomitant
Influenza Like Illness Other Serious 5/21/2006 61 Male 163 lb 11/29/2006 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Influenza Like Illness Other Serious 5/21/2006 61 Male 163 lb 12/15/2006 Other Health Professional United Kingdom
Primary
Secondary
Concomitant
Rash Generalised 9/1/2006 36 Female 124 lb 10/25/2006 Physician United States
Primary
Concomitant
Urticaria 7/15/2006 76 Male 277 lb 10/25/2006 Consumer United States
Primary
Concomitant
Rash 4/1/2006 76 Female 160 lb 10/25/2006 Consumer United States
Primary
Secondary
Concomitant
Injection Site Haemorrhage 6/1/2006 70 Female 132 lb 10/25/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2006 56 Female 199 lb 9/15/2006 Consumer United States
Primary
Concomitant
Weight Decreased 6/1/2005 48 Female 191 lb 10/16/2006 Consumer United States
Primary
Concomitant
Weight Increased 10/5/2005 59 Female 170 lb 10/16/2006 Consumer United States
Primary
Secondary
Concomitant
Vomiting Other Serious 9/3/2006 Male 185 lb 1/31/2007 Physician United States
Primary
Concomitant
Rash Generalised Other Serious 1/22/2007 Female 236 lb 2/16/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Sinus Headache Other Serious 63 Female 2/21/2007 Consumer United States
Primary
Concomitant
Splenomegaly Hospitalization 3/2/2007 7 Female 50 lb 3/28/2007 Consumer United States
Primary
Concomitant
Weight Increased 10/11/2006 65 Female 180 lb 12/11/2006 Consumer United States
Primary
Secondary
Concomitant
Drug Ineffective For Unapproved Indication 9/8/2006 67 Female 12/11/2006 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2006 56 Female 199 lb 12/11/2006 Consumer United States
Primary
Concomitant
Splenomegaly Hospitalization 3/2/2007 7 Female 50 lb 4/13/2007 Consumer United States
Primary
Concomitant
Weight Decreased 1/1/2006 66 Male 1/25/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Vaginal Haemorrhage 5/1/2006 44 Female 139 lb 1/25/2007 Consumer United States
Primary
Concomitant
Urticaria 11/1/2006 65 Female 228 lb 1/25/2007 Physician United States
Primary
Concomitant
Rash Generalised Other Serious 1/22/2007 Female 236 lb 5/1/2007 Consumer United Kingdom
Primary
Secondary
Concomitant
Splenomegaly Hospitalization 3/2/2007 7 Female 50 lb 5/4/2007 Consumer United States
Primary
Concomitant
Rash Generalised Other Serious 1/22/2007 Female 236 lb 5/7/2007 Physician United Kingdom
Primary
Secondary
Concomitant
Hypoaesthesia Other Serious 2/19/2007 59 Female 262 lb 5/25/2007 Other Health Professional United Kingdom
Primary
Concomitant
Blood Glucose Increased 12/18/2006 59 Male 270 lb 4/23/2007 Consumer United States
Primary
Concomitant
Drug Administration Error 2/6/2007 48 Male 230 lb 4/23/2007 Consumer United States
Primary
Concomitant
Injection Site Rash 51 Male 320 lb 4/23/2007 Physician United States
Primary
Concomitant
Blood Glucose Fluctuation 85 Female 4/23/2007 Consumer United States
Primary
Concomitant
Therapeutic Response Decreased 52 Male 285 lb 4/23/2007 Physician United States
Primary
Secondary
Concomitant
Glycosylated Haemoglobin Increased 3/23/2007 51 Male 195 lb 4/23/2007 Physician United States
Primary
Concomitant
Glycosylated Haemoglobin Increased 8/14/2006 14 Male 112 lb 4/23/2007 Physician United States
Primary
Concomitant
Anaphylactic Reaction Life Threatening 1/2/2007 55 Male 198 lb 4/23/2007 Other Health Professional United States
Primary
Secondary
Concomitant
Blood Urea Increased 66 Male 222 lb 4/23/2007 Physician United States
Primary
Concomitant
Weight Increased Other Serious 11/1/2006 Female 4/18/2007 Consumer United States
Primary
Secondary
Concomitant
Breast Cancer Other Serious 1/1/2000 57 6/5/2007 Consumer United States
Primary
Concomitant
Stomach Discomfort Female 4/10/2007 Consumer United States
Primary
Concomitant
Weight Increased 1/1/2007 42 Female 208 lb 4/10/2007 United States
Primary
Concomitant
Osteonecrosis Other Serious 3/30/2007 Male 7/9/2007 Physician United States
Primary
Concomitant
Therapeutic Response Increased 7/20/2007 Physician United States
Primary
Concomitant
Blood Glucose Increased 4/17/2007 65 Male 7/20/2007 Pharmacist United States
Primary
Concomitant
Sinus Congestion Other Serious 5/1/2007 48 Female 381 lb 9/4/2007 Other Health Professional United States
Primary
Concomitant
Sinusitis 12/23/2006 68 Male 208 lb 8/16/2007 Physician United States
Primary
Concomitant
Myalgia 5/1/2007 44 Male 10/22/2007 Other Health Professional United States
Primary
Concomitant
Rash Pruritic 75 Female 10/22/2007 Other Health Professional United States
Primary
Secondary
Blood Glucose Decreased 8/1/2007 69 Female 10/22/2007 Consumer United States
Primary
Concomitant
Blood Glucose Increased Female 10/22/2007 Consumer United States
Primary
Secondary
Concomitant
Urinary Tract Infection Other Serious 1/1/2005 56 Male 11/16/2007 Consumer United States
Primary
Concomitant
Vitamin D Decreased Other Serious 1/1/1982 Female 120 lb 11/30/2007 Consumer United States
Primary
Secondary
Concomitant
Urinary Tract Infection Other Serious 1/1/2005 56 Male 12/17/2007 Physician United States
Primary
Concomitant
Weight Decreased Other Serious 1/1/2005 Female 210 lb 2/15/2008 Consumer United States
Primary
Concomitant
Gastrooesophageal Reflux Disease Hospitalization 1/31/2008 39 Male 235 lb 3/18/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Pneumonia Other Serious 1/31/2008 Male 235 lb 3/19/2008 Other Health Professional United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/2006 70 Female 3/19/2008 Physician Brazil
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/2006 70 Female 3/31/2008 Physician Brazil
Primary
Secondary
Concomitant
Weight Increased Other Serious 12/28/2007 35 Female 104 lb 4/7/2008 Physician Japan
Primary
Secondary
Concomitant
Wrong Drug Administered Hospitalization Female 4/10/2008 Consumer United States
Primary
Concomitant
Weight Increased Other Serious 1/1/2001 53 Female 5/2/2008 Consumer United States
Primary
Secondary
Concomitant
Wrong Drug Administered Hospitalization Female 4/29/2008 Physician United States
Primary
Concomitant
Injection Site Pruritus Hospitalization 38 Female 190 lb 5/7/2008 Physician United Kingdom
Primary
Concomitant
Hallucination, Visual Hospitalization 3/27/2008 39 Male 149 lb 5/9/2008 Consumer United Kingdom
Primary
Concomitant
Weight Decreased Hospitalization 2/1/2007 Female 369 lb 5/2/2008 Consumer United States
Primary
Concomitant
Pneumonia Hospitalization 4/1/2008 59 Female 104 lb 5/27/2008 Physician Japan
Primary
Secondary
Concomitant
Injection Site Rash Hospitalization 35 Male 5/27/2008 Physician Ireland
Primary
Concomitant
Pneumonia Life Threatening 4/4/2008 59 Female 104 lb 6/13/2008 Physician Japan
Primary
Secondary
Concomitant
Pneumonia Life Threatening 4/4/2008 59 Female 104 lb 6/30/2008 Physician Japan
Primary
Secondary
Concomitant
Pruritus 11/1/2007 53 Female 7/7/2008 Consumer United States
Primary
Concomitant
Insulin Resistance Other Serious 8/1/2004 30 Female 141 lb 8/12/2008 Physician Japan
Primary
Secondary
Concomitant
Oedema Other Serious 8/1/2004 Female 146 lb 8/13/2008 Physician Japan
Primary
Concomitant
Insulin Resistance Other Serious 9/14/2007 33 Female 146 lb 8/15/2008 Physician Japan
Primary
Secondary
Concomitant
Vomiting 1/9/2008 44 Female 375 lb 7/7/2008 Consumer United States
Primary
Concomitant
Pneumonia Life Threatening 4/4/2008 59 Female 104 lb 9/3/2008 Physician Japan
Primary
Secondary
Concomitant
Insulin Resistance Other Serious 8/1/2004 30 Female 141 lb 9/5/2008 Physician Japan
Primary
Secondary
Concomitant
Injection Site Infection Hospitalization 8/1/2008 52 Male 9/9/2008 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 7/10/2008 50 Female 141 lb 9/15/2008 Consumer United Kingdom
Primary
Concomitant
Wrong Drug Administered Hospitalization 4/1/2008 47 Male 9/15/2008 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 3/1/2008 Female 224 lb 9/30/2008 United States
Primary
Concomitant
Coronary Artery Occlusion Hospitalization 2/12/2008 Male 10/2/2008 Physician United States
Primary
Concomitant
Injection Site Infection Hospitalization 7/25/2008 52 Male 10/13/2008 Consumer United States
Primary
Concomitant
Liver Disorder Other Serious 9/16/2008 54 Male 162 lb 11/3/2008 Physician Japan
Primary
Secondary
Concomitant
Liver Disorder Other Serious 9/16/2008 54 Male 162 lb 11/6/2008 Physician Japan
Primary
Secondary
Concomitant
Weight Decreased Other Serious 1/1/2006 Female 316 lb 11/18/2008 Physician United States
Primary
Concomitant
Pain Hospitalization 41 Female 211 lb 11/24/2008 Consumer United States
Primary
Concomitant
Vision Blurred Other Serious 7/10/2008 50 Female 141 lb 12/4/2008 Physician United Kingdom
Primary
Concomitant
Rash Pruritic Life Threatening 11/6/2008 63 Male 287 lb 12/8/2008 Other Health Professional United Kingdom
Primary
Concomitant
Coronary Artery Disease Death 11/25/2008 73 Female 86 lb 12/9/2008 Physician Japan
Primary
Concomitant
Rash Hospitalization 10/11/2008 87 Female 12/10/2008
Primary
Secondary
Concomitant
Rash Pruritic Life Threatening 11/6/2008 63 Male 287 lb 12/15/2008 Other Health Professional United Kingdom
Primary
Concomitant
Urticaria Other Serious 10/10/2008 88 Female 12/15/2008 Consumer France
Primary
Secondary
Concomitant
Upper Respiratory Tract Infection Other Serious 1/1/2007 Female 12/22/2008 Consumer United States
Primary
Secondary
Concomitant
Fear Hospitalization 9/1/2008 78 Female 11/5/2008 Consumer United States
Primary
Concomitant
Anaphylactic Reaction Life Threatening 12/11/2008 51 Male 245 lb 1/5/2009 Physician United States
Primary
Concomitant
Thrombosis Hospitalization 10/10/2008 59 Male 159 lb 1/21/2009 Other Health Professional United States
Primary
Secondary
Concomitant
Hypotension Hospitalization 11/5/2008 Male 1/23/2009 Other Health Professional France
Primary
Secondary
Concomitant
Hypotension Hospitalization 11/5/2008 56 Male 1/23/2009 Other Health Professional France
Primary
Secondary
Concomitant
Cytolytic Hepatitis Other Serious 12/8/2008 Male 1/28/2009 Other Health Professional France
Primary
Concomitant
Retinopathy Other Serious 68 Female 2/11/2009 Physician United Kingdom
Primary
Concomitant
Malaise Other Serious 69 Female 11/20/2008 Other Health Professional United States
Primary
Secondary
Loss Of Consciousness Required Intervention 5/1/2008 48 Female 11/20/2008 Consumer United States
Primary
Concomitant
Weight Decreased Hospitalization 5/23/2008 24 Male 11/20/2008 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Increased Hospitalization 11/20/2008 Physician United States
Primary
Concomitant
Hypoglycaemic Unconsciousness Life Threatening 1/17/2008 64 Female 11/20/2008 Consumer United States
Primary
Concomitant
Weight Decreased Hospitalization 5/23/2008 24 Male 11/21/2008 Consumer United States
Primary
Secondary
Concomitant
Malaise Other Serious 69 Female 11/20/2008 Other Health Professional United States
Primary
Secondary
Malaise Other Serious 69 Female 11/21/2008 Other Health Professional United States
Primary
Secondary
Unresponsive To Stimuli Other Serious 9/1/2007 80 Male 2/19/2009 Lawyer United States
Primary
Concomitant
Spondylitis Other Serious 1/1/2007 Female 2/17/2009 Consumer United States
Primary
Secondary
Concomitant
Weight Increased Other Serious 1/1/2006 Male 2/20/2009 Physician Canada
Primary
Concomitant
Insulin Resistance Other Serious 68 Female 2/27/2009 Physician United Kingdom
Primary
Concomitant
Weight Decreased Other Serious 1/1/2006 Female 316 lb 3/6/2009 Physician United States
Primary
Concomitant
Hypotension Hospitalization 11/5/2008 56 Male 141 lb 3/13/2009 Other Health Professional France
Primary
Secondary
Concomitant
Vomiting Hospitalization 12/22/2008 39 Female 127 lb 3/13/2009 Physician United States
Primary
Concomitant
Vitreous Detachment Other Serious 2/1/2007 Male 3/13/2009 Consumer United States
Primary
Concomitant
Erythema Other Serious 55 Female 3/17/2009 Physician Belgium
Primary
Secondary
Concomitant
Vomiting Hospitalization 12/22/2008 Female 127 lb 3/18/2009 Physician United States
Primary
Concomitant
Retinopathy Other Serious 68 Female 3/12/2009 Physician United Kingdom
Primary
Concomitant
Retinopathy Other Serious 68 Female 3/23/2009 Physician United Kingdom
Primary
Concomitant
Vomiting Hospitalization 12/22/2008 Female 127 lb 3/30/2009 Physician United States
Primary
Concomitant
Spondylitis Other Serious 1/1/2007 Female 3/26/2009 Consumer United States
Primary
Secondary
Concomitant
Type 2 Diabetes Mellitus Death 1/1/1996 45 Male 4/2/2009 United States
Primary
Concomitant
Hallucination Other Serious 62 Female 4/15/2009 Physician Japan
Primary
Concomitant
Hepatitis Acute Hospitalization 61 Male 4/24/2009 Physician Japan
Primary
Secondary
Concomitant
Hallucination Other Serious 2/1/2009 62 Female 123 lb 4/30/2009 Physician Japan
Primary
Concomitant
Wrong Drug Administered Other Serious 4/1/2009 33 Male 5/8/2009 Consumer United States
Primary
Secondary
Concomitant
Insulin Resistance Other Serious 68 Female 5/14/2009 Physician United Kingdom
Primary
Concomitant
Hepatic Enzyme Increased Other Serious 16 Female 5/20/2009 Physician Belgium
Primary
Secondary
Concomitant
Hallucination Other Serious 2/1/2009 62 Female 123 lb 5/21/2009 Physician Japan
Primary
Concomitant
Visual Impairment Hospitalization 6/1/2006 52 Female 187 lb 5/26/2009 Lawyer United States
Primary
Concomitant
Diabetic Retinopathy Other Serious 8/20/2001 46 Male 177 lb 6/5/2009 United States
Primary
Concomitant
Liver Disorder Hospitalization 12/26/2008 61 Male 137 lb 6/9/2009 Physician Japan
Primary
Secondary
Concomitant
Hepatic Function Abnormal Other Serious 5/11/2009 68 Male 6/11/2009 Physician Japan
Primary
Concomitant
Blood Glucose Increased 62 Female 7/21/2008 Consumer United States
Primary
Concomitant
Blood Glucose Increased 65 Male 7/21/2008 Consumer United States
Primary
Concomitant
Blood Glucose Increased Male 7/21/2008 Consumer United States
Primary
Secondary
Concomitant
Blood Glucose Increased 4/16/2008 81 Female 7/21/2008 Consumer United States
Primary
Concomitant
Blood Glucose Decreased 4/28/2008 51 Male 7/21/2008 Consumer United States
Primary
Secondary
Concomitant
Product Quality Issue Other Serious 9/4/1988 39 Female 122 lb 7/4/2009 Consumer United States
Primary
Secondary
Vomiting Other Serious 4/1/2009 63 Female 145 lb 7/15/2009 Physician United States
Primary
Secondary
Concomitant
Death Death Female 302 lb 7/30/2009 Physician United States
Primary
Concomitant
Weight Increased Other Serious 1/1/1996 Female 180 lb 8/4/2009 Consumer United States
Primary
Secondary
Concomitant
Urosepsis Other Serious 4/1/2009 63 Female 145 lb 8/7/2009 Physician United States
Primary
Secondary
Concomitant
Polyneuropathy Other Serious 7/22/2008 63 Female 209 lb 8/18/2009 Other Health Professional United States
Primary
Concomitant
Pain Hospitalization 41 Female 211 lb 8/27/2009 Consumer United States
Primary
Concomitant
Weight Increased Hospitalization 1/1/2007 Female 191 lb 8/27/2009 Consumer United States
Primary
Concomitant
Injection Site Swelling Hospitalization 7/20/2009 Male 115 lb 8/31/2009 Physician Japan
Primary
Secondary
Concomitant
Diabetic Neuropathy Other Serious Female 191 lb 9/3/2009 United States
Primary
Secondary
Concomitant
Heart Rate Increased Other Serious 1/1/2009 Male 9/4/2009 Consumer United States
Primary
Secondary
Concomitant
Injection Site Swelling Hospitalization 7/20/2009 Male 115 lb 9/11/2009 Physician Japan
Primary
Secondary
Concomitant

Drug Data